Among mammalian species specific inborn deficiencies involving a single complement component have been defined in rabbits (19) and mice (20) , and a deficiency within the classical third component complex has been established in guinea pigs (21) . The present paper defines an inborn deficiency of the second component of human complement. Affected individuals have been identified in each of the three generations of a kindred. Methods Serum samples were separated from freshly clotted blood specimens that had been allowed to stand at room temperature for 30 minutes and then centrifuged at 0 to 40 C. All sera were then either immediately stored as small portions at -650 C or, if transported, frozen and kept in dry ice. The transported sera were then thawed, quickly subdivided into small portions, and stored at -650 C. A serum sample was thawed once for determinations involving the complement system.
Determination of the serum hemolytic complement titer (C'Hs0). The method used was a 3-ml modification (22) of the 7.5-ml assay of Kabat and Mayer (23) . Consequently, all reagents used in the titration were decreased in volume by 60%. This method yielded results comparable to the 7.5-ml volume titration (24) . Sheep erythrocytes 1 and hemolysin2 were obtained, and the same lot of hemolysin was used for all hemolytic de- terminations. Saline-barbital buffer, pH 7.3, with 0.1% wt/vol crystallized bovine plasma albumin s and the sensitized sheep erythrocyte suspension have been described (23) . The complement titer was obtained by plotting the log (y/l -y), where y equals the per cent of lysis, against the volume of diluted serum on 2-X 3-cycle log log graph paper. When sera at low dilutions were used in the titrations, serum blanks were included, and the optical density of these was subtracted from that of the lysates in tubes containing serum as a correction for serum color.
Titration of the serum complement components. Reagents (R1, R2, R3, R4) each deficient in one of the four classical complement components were prepared from fresh human serum and stored at -650 C. The volume of reagent used in the titration of each complement component yielded complete lysis in recombination with each of the other three reagents and by itself lysed less than 5% of the sensitized sheep cell suspension used in the assay. Titrations were performed by the method described by Wedgwood (25) . All titrations were performed simultaneously with a known normal serum control.
The second component of complement of human serum was also assayed with the stoichiometric titration of Austen and Beer (26) , employing sensitized sheep erythrocytes persensitized with guinea pig first and fourth complement components (EACtlagP,49P). The possibility that the C'2hu titer, as measured by the interaction of whole serum and EAC'lagP,49P cells, requires the participation of human fourth component of complement (C'4hu) was suggested by Nelson (2) and has recently been confirmed (27) . Apparently C'lagP, transferred from SAC'la9P,49P sites, reacts with C'4hu to form SAC'lagP,4h' sites early in the tmax period; the stoichiometric titration of C'2hu is then due primarily to the interaction of this component with the newly formed SAC'lagP,4hu sites rather than with SAC'lagP,40 sites.
Since the source of C'4 cannot be designated with absolute certainty, the sites formed by the interaction of whole human serum with EAC'lagP,49P cells have been designated SAC'lagP,4*,2h' in Results. Sheep erythrocytes and hemolysin for this assay were obtained commercially.4 Second component titrations were performed with a reference normal serum of known C'2 content, and all values were corrected to an assigned base value for the reference serum (28) . The R2 used for the second component titrations contained 28 C'2 U per ml when assayed with an EAC'la",49P cell titration.
Equal amounts of standardized EAC'lagP,49P cells were mixed with a 1: 500 dilution of normal human serum or with a 1: 10 dilution of C'2 deficient human serum to determine the incubation time at which the greatest number of sites on the erythrocyte surface are converted from SAC'lagP,4E9 to SAC'la",4*,2'. This optimal incubation time is termed the tmax time.
The effect of adding highly purified C'2 to C'2 deficient serum. Highly purified human C'2 (29) 5 in buffer containing 1 X 10' M EDTA and 1 X 10' M dithioerythritol represented an approximate 30-fold concentration of the serum C'2 content. We added 0.04 ml of the purified human C'2 to 1 ml of C'2 deficient serum, and we measured hemolytic serum complement activity and the C'2 titer in the reconstituted serum with the methods described above. Functionally pure guinea pig C'2 f (30) was added in in-creasing amounts of up to 120 U per ml to a 1: 40 dilution of C'2 deficient human serum. The mixture volume was kept constant at 0.4 ml. Standardized sensitized sheep erythrocytes (23), 0.4 ml, and barbital buffer were added to make a total volume of 3 ml. The per cent of lysis was determined for each increment of functionally pure guinea pig C'2 added and then plotted against units of guinea pig C'2 added on arithmetic graph paper. The amount of functionally pure guinea pig C'2 required for 50% lysis was then obtained by plot.
Immunodiffusion studies of the serum betalc (C'3)-, beta1, (C'4)-, and betalF (C'5)-globulins and C'1 esterase inhibitor. Immunoelectrophoresis was performed with the method of Scheidegger (31) . Rabbit anti-betavobetalE-globulin 7 and goat anti-betaic-globulin 8 were obtained commercially. The latter serum also gave a precipitation band with betaF,-globulin. Rabbit anti-betaicglobulin was prepared by injecting rabbits with pure human betaic-globulin isolated by the method of MullerEberhard, Nilsson, and Aronsson (32) . Rabbit antiserum to C'1 esterase inhibitor was prepared by injecting rabbits with purified C'1 esterase inhibitor (E-I).9 All patterns were developed at room temperature and stained with amido black.
The serum betaic-globulin was determined by quantitative immunodiffusion, as described by Klemperer and his co-workers (34) . Conversion of serum betaic-globulin was assessed by adding washed rabbit antihuman gamma globulin-gamma globulin precipitates to normal and to C'2 deficient human sera. The mixtures were incubated in a 370 water bath and samples removed at 20-minute intervals. The further conversion of betaic-globulin was prevented by delivering the samples into buffered pH 7.4 EDTA at 0°C. Sera incubated without the addition of washed immune precipitates were used as controls. The conversion of serum beta1c-globulin was estimated by use of immunoelectrophoresis. A similar experiment was performed in which the washed immune precipitates were added to sera containing buffered EDTA at 0.01 M final concentration.
The serum concentration of C'1 esterase inhibitor was determined by immunodiffusion with the technique described by Rosen, Charache, Pensky, and Donaldson (35) . Functional serum C'1 esterase inhibitor activity was measured by the method of Levy and Lepow (36) .
Determination of the serum bactericidal capacity. The bactericidal capacity of the sera tested was determined by the method of Michael, Whitby, and Landy (37), using Salmonella typhosa 0901. Bactericidal assays were performed using unabsorbed serum. In all assays 0.1 ml of immune rabbit anti-S. typhosa 0901 serum was added to the system, so that the reactions were carried out with serum complement as the limiting factor. In the assay the end point was interpreted as the serum dilution 7 Anticomplement (f8lc/P1E-globulin) (Behringwerke), obtained from Diagnostic Reagents Division of Lloyd Brothers, Inc., Cincinnati, Ohio. 8 Hyland Laboratories.
at which 50% of the organisms by colony count were killed. C'2 deficient human serum reconstituted with highly purified human C'2 was also tested for its bactericidal activity. C'2 deficient serum was run in parallel with the same serum reconstituted. Determination of the serum complement titer by nmmune adherence (C'I-A30). The immune-adherence titer was determined by a modification of the method of Woodworth (38) using a Brucella abortus-anti-Br. abortus system (39) . Br. abortus 10 was washed twice in barbital buffer by centrifuging at 6,600 X g for 15 minutes. Anti-Br. abortus was obtained commercially.1' The optimal dilutions of antibody and antigen were determined by two-dimensional titration of anti-Br. abortus 1: 160 vs. Br. abortus suspension giving an optical density of 0.150 at 650 m~u measured with a Beckman DU spectrophotometer. The test system was composed of 0.2 ml antigen, 0.2 ml antibody, 0.5 ml human serum dilutions, and 0.1 human type "O" erythrocytes that had been standardized so that the optical density of a 1: 10 lysate equaled 0.395 at 541 m/A in a Beckman DU spectrophotometer.
This erythrocyte suspension contained approximately 2.6 X 107 cells per ml. All reagents were made up with saline-barbital buffer containing bovine plasma albumin. Adherence of Br. abortus to human erythrocytes was determined by counting 100 organisms under phase contrast at 900 X magnification. The number of organisms adherent to the human erythrocytes equaled the per cent adherence at a given serum dilution. All determinations were made in duplicate, and the average per cent adherence vs. serum dilution was plotted on semilog paper. The serum dilution at which 30% of the organisms were adherent to the erythrocytes was obtained by plot. This was designated the C'I-A3o. A reference serum with an assigned C'I-A30 of 1,280 was included with all I-A determinations, and all values were adjusted to this reference serum as a standard. The effect of reconstituting C'2 deficient human serum with highly purified human C'2 was also determined by using this method.
C'2 deficient serum was run in parallel with the same serum reconstituted.
Medical histories of C'2 deficient individuals. The propositus (III, 7) is a 45-year-old male. He had measles, mumps, chicken pox, and scarlet fever during childhood without any untoward complications or sequelae. He has never had any undue susceptibility to infection. At 40 he had acute maxillary sinusitis treated by irrigation of the sinus with penicillin. Nine days later he developed a severe serum sickness type of penicillin reaction with redness, swelling and pain in both ankles, arthralgia of the elbows and wrists, an edematous vesicular eruption of the feet, and urticaria of the trunk. The symptoms were ameliorated by triamcinolone. He has had poison ivy once. At 25 he was found to be tuberculin-positive, and at 37 he gave a positive response to first 10 Diagnostic tube antigen, Br. abortus; Sylvana Chemical Co., Orange, N. J. 11 Agglutinating serum, Br. abortus; Burroughs Wellcome & Co., Tuckahoe, N. J. strength purified protein derivative. The deficiency was discovered by the propositus while performing studies on immune adherence with his own serum.
A sister of the propositus (III, 10) is 43 years old. She had uncomplicated varicella, rubeola, and mumps during childhood. At age 11 she had bilateral pneumonia with empyema. She was again hospitalized for pneumonia at 24. At 34 she had an episode of pleurisy, considered to be of viral etiology. During the same year a hand infection complicated by lymphadenitis was successfully treated with antibiotics. She had otitis media at ages 6, 8, and 21 years. She has never had an untoward reaction to penicillin, One episode of mild poison ivy was sustained in childhood. The tuberculin reaction was negative when last tested 20 years ago.
A brother of the propositius (III, 11) is 40 years old. He had measles, chicken pox, and mumps without complication during childhood. He had two episodes of otitis media as a child. He has had poison ivy. He has no undue susceptibility to infection. He has received penicillin for minor upper respiratory infections. After one such injection at age 27 he developed a swollen, painful, red ankle, thought to be due to a penicillin reaction.
Results
Members from three generations of a kindred were investigated by using the methods described above (Figure 1 , Tables I and II) . Individuals with decreased serum complement activity were found in each of the three generations.
Hemolytic complement titers of the sera of family members. The propositus (III, 7) and his sister (III, 10) and brother (III, 11) were found to have no demonstrable serum hemolytic activity. The sera of their spouses were found to have normal hemolytic complement activity (38 to 42 C'H50 U per ml). The offspring of these matings (IV, 3 to 13) were found to have serum hemolytic complement titers that were below the lower limit of normal (20 to 24 C'H50 U per ml Table II) . A sister of the propositus whose serum contained 22 C'H50 U married an individual with a normal serum complement titer. Of their two children, a boy (IV, 1) has a normal serum complement titer, and the serum of the other, a girl (IV, 2) has 24 C'H50 U per ml.
The sera of the mother (II, 5) of the propositus and a maternal aunt (II, 6) contain 24 and 28 C'H5o U per ml, respectively. A maternal aunt (II, 4) and two maternal uncles (II, 7 and 9) have normal serum hemolytic complement activity. Titration of the serum complement components. When sera from members of this family were studied for C'2 activity, results consistent with those obtained by measuring the total serum hemolytic complement titers were noted (Tables I and II) . As determined by the reagent method, three individuals (III, 7, 10, and 11) had C'2 titers of 3 to 6 U C'2 (normal = 128 U), and 15 (II, 5 and 6; III, 5; IV, 2 to 13) had subnormal titers ranging from 24 to 64 U C'2. Individuals who had normal C'H,, were found to have normal C'2 titers by the reagent method (IL 4, 7, and 9; III, 2 and 3; IV, 1). When C'2 activity was measured with the EAC'lagP,49P cell assay, concordant results were obtained (Tables I and II) . Three individuals each had C'2 activity of less than 3 U per ml (normal = 350 to 670). Fifteen individuals had subnormal levels (184 to 316 U per ml). Individuals with normal serum -hemolytic activity had normal C'2 activities with the EAC'lagP,49P assay.
The tmax, the time at which the greatest number of sites are in the SAC'lagP,4*,2hu state, was determined by using C'2 deficient human serum as the source of C'2. The number of SAC'lagP,4*,2hu sites per cell was determined from samples taken from 30 seconds' to 28 minutes' incubation. At no time was even one SAC'lagP,4*,2hu site per cell formed (Figure 2) . At 2 minutes of incubation time a minimal amount of SAC'lagP,4*,2hu formation was measured in the C'2 deficient serum.
To ascertain whether any of the three other classical complement components were involved in the hemolytic defect, we performed titrations using the classical reagent method. In all sera tested, the titers of C1, C'3, and C'4 were found to be normal (Table I ).
The effect of adding highly purified C2 to C'2 deficient serum. An amount of highly purified human C'2 calculated to restore the serum complement activity to a normal level was added to C'2 deficient serum. The complement activity of the reconstituted serum was then measured by hemolytic assay, and the serum was found to contain 36 C'H50 U per ml (Table III) . When the reconstituted serum was assayed for C'2 activity utilizing the EAC'lagP,49P cell titration, a normal value (339 U) was also obtained (Table III) . When functionally pure guinea pig C'2 was added to a 1:40 dilution of C'2 deficient human serum 1 C'H50 U was restored with 16 U of guinea pig C'2. In order to ascertain whether or not. C'2 deficient serum blocked the interaction of hemolytically active C'2 with SAC'la,4 sites, we added a 1: 10 dilution of serum from an individual deficient in C'2 to functionally pure guinea pig C'2 and measured the resulting C2 activity by the stoichiometric EAC'lagP,49P cell titration. The resulting C'2 titer was identical to that obtained when functionally pure guinea pig C'2 was diluted with the same amount of saline. This experiment was repeated with normal human serum as the source of C'2. The same results were obtained; there was no change in C'2 activity when C'2 deficient human serum was added (Figure 3) . Thus, the C'2 deficient serum did not appear to contain an inhibitor or an altered protein that could attach to SAC'la"P,49P sites and block the activity of guinea pig or human C'2. Immunodiffusion studies of the serum beta1c-globulin (C'3), betall,-globulin (C'4), betalp-globulin (C'S), and C'1 esterase inhibitor. The sera of both C'2 deficient individuals (III, 7 and 10) and an individual with a subnormal C'2 titer (III, 5) contained normal amounts (130 to 155 mg per 100 ml) of beta1c-globulin when measured by a quantitative immunodiffusion technique (Table  I) . When the serum of a C'2 deficient individual (III, 10) was investigated by immunoelectrophoresis against antisera identifying human serum betalc-globulin, betalE-globulin, and betalF-globulin, we found that normal bands of precipitation were developed for these three globulins.
When a washed immune gamma globulin-antigamma globulin precipitate was added to C'2 deficient human serum, conversion of beta1c-globulin occurred. The conversion was about 75 % The effect of adding highly purified human C'2 to C'2 deficient serum C'2 defi-C'2 defi- To ascertain that the deficiency in the kindred described was not an asymptomatic variant of hereditary angioneurotic edema, both quantitative immunodiffusion and functional determinations of C'1 esterase inhibitor were performed. The level of this protein was found to be normal (2.4 + 0.4 mg per 100 ml) in both C'2 deficient and C'2 intermediate individuals (Table I) . The serum from a C'2 deficient individual yielded a normal pattern in immunoelectrophoresis against rabbit antihuman C'1 esterase inhibitor (Figure 4) . The functional serum C'1 esterase inhibitor titer of this serum was normal, 4.5 U per ml.
Serum bactericidal activity of family members. The sera of three C'2 deficient individuals (III, 7, 10, and 11) had demonstrable but decreased in vitro bactericidal activity against S. typhosa 0901. A 509%o bactericidal end point was obtained with a serum dilution 1: 3 (normal = 1: 25, Table  I ). Two sera with subnormal C'2 (II, 5 and III, 5) had bactericidal titers of 1: 15 (Table I) human C'2 to a normal hemolytic activity and C'2 titer also had normal bactericidal activity, 1: 25.
Serum complement activity of family members as determined by the method of immune-adherence (C'I-A3o). The sera of three C'2 deficient individuals (III, 7, 10, and 11) were found to have activity of one-ninth to one-fortieth of normal (760 to 1,440 U per ml, Figure 5 ). Two individuals with subnormal serum C'2 (II, 5 and III, 5) had more than one-half of normal immuneadherence activity, a finding similar to that obtained with the hemolytic complement titration ( Figure 5 , Table I ). C'2 deficient serum reconstituted with highly purified human C'2 so that it then contained normal hemolytic activity and C'2 titer also had normal immune-adherence activity (1,390 U per ml).
Discussion
A hereditary deficiency of the second component of complement in a kindred is described in this report; the defect has been identified in members from three generations. The sera of three siblings are almost totally deficient in C'2 activity. The sera of the mother, a maternal aunt, a sister, a niece, and the 11 children of the individuals deficient in C'2 were found to be partially deficient in C'2. The defect appears to be transmitted as an autosomal recessive characteristic, although indi (40) is synthesized as a gene product or the abnormal allele. However, we have shown in this report that C'2 deficient sera do not contain a gene product that functionally competes or interferes with normal hemolytically functional C'2. Sera deficient in hemolytic C'2 were also found to be defective in two other complement dependent systems, immune adherence and bacteriolysis. Sera from individuals homozygous for the C'2 deficiency had 10 to 15% of normal immune adherence and bactericidal activity, whereas sera of heterozygous individuals contained 50%o of the normal activity in these two complement dependent systems. Furthermore, the conversion of ,e3c-globulin to /3lG-globulin, which has been considered to be a C'2 dependent reaction, has been demonstrated in C'2 deficient serum, although the conversion proceeds at a very retarded rate. It is possible that the C'2 deficient sera contain sufficient C'2 molecules to effect detectable activity in the possibly more sensitive immune adherence and bactericidal assays, whereas they would be functionally undetected in the hemolytic assay used here. Alternatively, other pathways may exist to the activation of classical third component activity with resultant detectable bactericidal and immuneadherence activity. The hemolytic, bactericidal, and immune adherence activities of C'2 deficient serum were fully restored upon the addition of highly purified human C'2.5 These observations suggest that the sera are C'2 deficient by virtue of a single error of protein biosynthesis, and that the protein is functionally operative in the three complement dependent systems studied.
The existence of primary complement deficient states in man has been previously reported. Scartozzi (41) (43) . They noted that 14 individuals were deficient in serum hemolytic complement activity. With a complement reagent method, a decrease in C'2 or C'4 was found in the sera of the majority of these individuals. The medical histories of these individuals did not establish any underlying illness or yield any information to distinguish these recruits from others. No specific attempt to exclude hereditary angioneurotic edema as the basis for the decreased serum hemolytic complement titer and for the decrease in C'2 and C'4 was reported by the authors. The families of 13 of the recruits were investigated, but no definite hereditary pattern could be established in any kindred.
Kumate (44) has recently studied two brothers, one of whom had recurrent bacterial meningitis. Both boys had a decrease in serum hemolytic complement activity, and the defect was found to be limited to C'2. Six other siblings and both parents of the propositus were found to have normal serum hemolytic complement activity and normal C'2 titers. Whereas no definite genetic transmission could be established in this family, the possibility of an autosomal recessive mode of transmission with only those homozygous for the abnormal gene having a detectable defect is not excluded.
In man the only genetically determined abnormality of the serum complement system thus far established is hereditary angioneurotic edema. Donaldson and co-workers (18, 35) have shown that there is a hereditary biosynthetic defect in the inhibitor of the esterase of C'1 in this disease. During attacks of hereditary angioneurotic edema activated C'1 esterase is demonstrable in the plasma of the patients. and s concomitant drm;nntion of C'2 and C'4 titers is demonstrable (18, 27) . The sera of the kindred reported here have normal C'1 esterase inhibitor and C'4 titers: consequently, the C'2 deficient individuals do not have hereditary angioneurotic edema.
Several heritable complement deficiencies are known in laboratory animals. Moore (21) de-scribed a complement deficient strain of guinea pigs. The defect was transmitted as an autosomal recessive trait and was found to involve the classical C'3 complex as defined by assays employing reagent methods (45) . In 1961, Rother and Rother (19) found a strain of complement deficient rabbits. Rother and Rother found the sera of these rabbits to lack C'6 (46) . As yet the exact genetic transmission of the defect has not been established.
Two strains of inbred mice deficient in hemolytic serum 'complement were reported by Rosenberg and Tachibana in 1962 (20) . The defect has been demonstrated to be limited to C'5 (47) . Since the initial report several other inbred strains of mice have been found that lack serum hemolytic complement activity (48) . The hemolytic defect appears to be transmitted genetically as an autosomal recessive trait determined by the gene locus Hc0. Mice possessing the allelic gene locus Hc have hemolytic complement activity, and no genedose phenomenon has been noted (49) The relative freedom from bacterial infection of the three C'2 deficient individuals is consistent with experiments performed with C'5 deficient mice and C'6 deficient rabbits. Stiffel and his co-workers (50) have reported that complement deficient mice have normal in vivo bactericidal activity when challenged with intravenously administered Salmonella typhimurium. Similar results were obtained by Rother and Rother with complement deficient rabbits challenged intravenously with S. typhosa. When the sera from complement deficient rabbits were used in an in vitro bactericidal assay against S. typhosa, no bactericidal activity could be demonstrated (45) . In both of the in vivo experiments the injected bacteria were phagocytosed principally by the reticuloendothelial cells of the liver.
The three homozygous C'2 deficient individuals in this kindred are in apparent good health and have manifested both delayed hypersensitivity (poison ivy, tuberculin skin test) and penicillininduced serum sickness. The role of complement in the defense mechanisms of the intact organism remains unclarified. Summary A hereditary deficiency of the second component of complement in man has been established. The abnormality is defined by a virtual absence of hemolytic activity measured either as whole complement (C'H50) or C'2. Titrations of C'1, C'3, and C'4 by the classical reagent methods are normal in affected individuals. Levels of serum C'1 esterase inhibitor, beta1c-globulin (C'3), betaiFglobulin (C'5), and betalE--globulin (C'4), are also normal. Immune-adherence complement titers using a Br. abortus system are severely decreased as is the in vitro serum bactericidal activity against S. typhosa. Evidence is presented which indicates that the defect is caused by a biosynthetic defect of the functional protein.
